Companies / United Arab Emirates
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
UAE Tightens Bioequivalency Laws
February 2007 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
The Ministry of Health in the UAE has tightened its laws on generic drugs, in wake of an expected surge in demand for these treatments, as the private insurance market is expected to take off. Under the new rules, generic drugs will have to be endorsed by accredited bioequivalence centres, which will be set up throughout the